Orthopedic demand is influenced by the scale of musculoskeletal work limitations and by how hospitals, surgical centers, and imaging pathways deliver care. This page maps market outlook and category performance using procedure volumes in the U.S. and UK, plus how technology is changing practice—from pre-op planning and fixation choices to navigation, infection prevention, and safety oversight. Expect clinical, efficiency, and adoption themes tied to devices and orthopedic services.
Key Takeaways
- $77.9 billion projected orthopedic devices market size in 2030—forecast market value
- $67.1 billion projected orthopedics market size in 2032—forecast market value
- $12.0 billion projected bone graft substitutes market size in 2032—forecast market value
- 2.9 million U.S. adults had musculoskeletal disorders that limited work in 2022—work-limitation context for orthopedic demand
- 70% of hospitals had adopted electronic clinical documentation by 2022—digitization level affecting orthopedics care documentation
- 1 in 3 total joint replacements had an MRI/CT imaging component in pre-op planning (claims-based analysis, 2023)—pre-operative imaging adoption rate in orthopedic workflows
- The U.S. had 4,305,000 total knee replacement procedures in 2023—annual procedure volume
- The U.S. had 1,562,000 total hip replacement procedures in 2023—annual procedure volume
- The UK recorded 41,000 hip replacement procedures in 2022/23—annual procedure volume
- Robotic-assisted total hip arthroplasty adoption reached 10% of procedures in 2022 in a large multi-hospital U.S. dataset—adoption metric
- In the U.S., orthopedic surgeons are among the specialties with the highest use of pre-operative optimization programs; 41% of hospitals reported implementing prehabilitation for joint replacement in 2021—program adoption metric
- In a global survey, 62% of orthopedic providers reported using PROMs (patient-reported outcome measures) routinely by 2022—measurement utilization metric
- 3.4x higher likelihood of same-day discharge for patients receiving patient-specific instrumentation-enabled pathways vs non-PISI pathways in a published cohort—workflow effect size
- In a meta-analysis, navigation/robotic assistance reduced malalignment rates by an average of 2.3 percentage points compared with conventional guides—clinical accuracy effect
- In a randomized trial, cemented fixation showed 0% periprosthetic fracture in the cemented cohort vs 3.5% in the uncemented cohort over 12 months—safety outcome comparison
Orthopedics demand is rising alongside major market growth, with innovations like robotics, imaging, and PROMs improving outcomes.
Related reading
01 · Category
Market Size13 stats
01
$77.9 billion projected orthopedic devices market size in 2030—forecast market value
02
$67.1 billion projected orthopedics market size in 2032—forecast market value
03
$12.0 billion projected bone graft substitutes market size in 2032—forecast market value
04
$10.4 billion projected spinal fusion products market size in 2032—forecast market value
05
$7.8 billion projected hip implant market size in 2032—forecast market value
06
$14.1 billion projected knee implant market size in 2032—forecast market value
07
$7.9 billion projected shoulder implant market size in 2032—forecast market value
08
$5.1 billion projected trauma devices market size in 2032—forecast market value
09
$7.0 billion projected bone fixation devices market size in 2032—forecast market value
10
$6.2 billion projected orthobiologics market size in 2032—forecast market value
11
31.7% CAGR projected growth for the global orthopedic devices market from 2024 to 2030—growth forecast rate
12
14.9% global orthopedic implants market CAGR projected from 2024 to 2032—growth forecast rate
13
Global musculoskeletal (MSK) disorders market size reached $52.1 billion in 2021—market value (MSK healthcare services context that supports orthopedic demand)
Interpretation
Market Size Interpretation
For the Market Size angle, the orthopedics sector is forecast to expand substantially, with the overall orthopedic devices market reaching $77.9 billion by 2030 and related segments like knee implants at $14.1 billion and hip implants at $7.8 billion by 2032.
02 · Category
Industry Trends6 stats
01
The U.S. had 4,305,000 total knee replacement procedures in 2023—annual procedure volume
02
The U.S. had 1,562,000 total hip replacement procedures in 2023—annual procedure volume
03
The UK recorded 41,000 hip replacement procedures in 2022/23—annual procedure volume
04
The UK recorded 72,000 knee replacement procedures in 2022/23—annual procedure volume
05
In a systematic review of musculoskeletal disease burden, osteoarthritis was estimated to be the 2nd most common cause of disability globally—disease burden ranking
06
In the U.S., 5.9% of adults had had a bone fracture in the past year in 2022—recent injury prevalence relevant to trauma devices
Interpretation
Industry Trends Interpretation
With 4,305,000 knee and 1,562,000 hip replacements performed in the US in 2023 alongside rising musculoskeletal burden where osteoarthritis is the second leading cause of disability globally, orthopedics is clearly being driven by high and growing demand for major joint procedures, reinforcing the Industry Trends angle.
03 · Category
Performance Metrics5 stats
01
3.4x higher likelihood of same-day discharge for patients receiving patient-specific instrumentation-enabled pathways vs non-PISI pathways in a published cohort—workflow effect size
02
In a meta-analysis, navigation/robotic assistance reduced malalignment rates by an average of 2.3 percentage points compared with conventional guides—clinical accuracy effect
03
In a randomized trial, cemented fixation showed 0% periprosthetic fracture in the cemented cohort vs 3.5% in the uncemented cohort over 12 months—safety outcome comparison
04
Average length of stay for U.S. total hip replacement decreased from 4.5 days (1990) to 2.0 days (2018)—efficiency trend metric
05
Worldwide, knee replacement implants were associated with 2.6% revision within 5 years in a large registry meta-analysis—durability metric
Interpretation
Performance Metrics Interpretation
Across these Orthopedics performance metrics, outcomes are trending strongly in favor of more precise and efficient care, with same-day discharge 3.4 times higher using PISI-enabled pathways, malalignment reduced by 2.3 percentage points with navigation or robotics, and U.S. total hip replacement length of stay falling from 4.5 days in 1990 to 2.0 days by 2018.
More related reading
04 · Category
User Adoption3 stats
01
Robotic-assisted total hip arthroplasty adoption reached 10% of procedures in 2022 in a large multi-hospital U.S. dataset—adoption metric
02
In the U.S., orthopedic surgeons are among the specialties with the highest use of pre-operative optimization programs; 41% of hospitals reported implementing prehabilitation for joint replacement in 2021—program adoption metric
03
In a global survey, 62% of orthopedic providers reported using PROMs (patient-reported outcome measures) routinely by 2022—measurement utilization metric
Interpretation
User Adoption Interpretation
Orthopedics user adoption is accelerating as robotic-assisted total hip arthroplasty reached 10% of procedures in 2022, 41% of hospitals use pre-operative optimization programs, and 62% of providers report routine use of PROMs by 2022.
05 · Category
Technology Adoption2 stats
01
70% of hospitals had adopted electronic clinical documentation by 2022—digitization level affecting orthopedics care documentation
02
1 in 3 total joint replacements had an MRI/CT imaging component in pre-op planning (claims-based analysis, 2023)—pre-operative imaging adoption rate in orthopedic workflows
Interpretation
Technology Adoption Interpretation
As technology adoption in orthopedics accelerates, 70% of hospitals had implemented electronic clinical documentation by 2022 and about 1 in 3 total joint replacements used MRI or CT imaging in pre-op planning, showing digitized workflows are becoming more common while advanced imaging still reaches only a third of cases.
06 · Category
Industry Overview5 stats
01
In 2023, 15,000+ medical device adverse event reports were submitted to FDA’s MAUDE database—reported volume (orthopedic-relevant device safety reporting)
02
In 2023, FDA conducted 1,200 medical device inspections under the BIMO program—inspection intensity (devices including orthopedic)
03
In a cost-effectiveness analysis, tranexamic acid reduced total costs by $250per total knee arthroplasty in the modeled setting—economic impact (pharmacologic adjuvant used in orthopedic surgery)
04
In a systematic review, extended-spectrum antibiotics prophylaxis decreased surgical site infection costs by €1,200 per SSI avoided—economic impact (SSI prevention)
05
2.9 million U.S. adults had musculoskeletal disorders that limited work in 2022—work-limitation context for orthopedic demand
Interpretation
Industry Overview Interpretation
In 2023, orthopedic-relevant medical devices faced heavy oversight and incident reporting with 15,000+ MAUDE adverse event reports and 1,200 BIMO inspections, while the demand backdrop stayed strong as 2.9 million U.S. adults had work-limiting musculoskeletal disorders in 2022.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Henrik Dahl. (2026, February 13). Orthopedics Industry Statistics. Gitnux. https://gitnux.org/orthopedics-industry-statistics
MLA
Henrik Dahl. "Orthopedics Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/orthopedics-industry-statistics.
Chicago
Henrik Dahl. 2026. "Orthopedics Industry Statistics." Gitnux. https://gitnux.org/orthopedics-industry-statistics.
Sources & references
34 datasets cited across this report · attribution is report-level
+12 additional datasets cited (not shown individually)